Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124937) titled 'The efficacy and safety of High-intensity Focused Ultrasound (HIFU) combined with Serplulimab and Fruquintinib Therapy in Colorectal cancer Liver Metastases' on May 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhongshan Hospital (Xiamen), Fudan University
Condition:
Colorectal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311997
Disclaimer: Curated by HT Syndication....